Magnesium in depression

Pharmacological Reports

Volumn 65, Issue 3, 2013, Pages 547-554

  Serefko, Anna ^a   Szopa, Aleksandra ^a   Wlaź, Piotr ^b   Nowak, Gabriel ^c,d   Radziwoń Zaleska, Maria ^e   Skalski, Michał ^e   Poleszak, Ewa ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

^b MARIA CURIE SK ODOWSKA UNIVERSITY   (Poland)

^c INSTITUTE OF PHARMACOLOGY   (Poland)

^d JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^e MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Antidepressant therapy; Antidepressant like effect; Depression; Magnesium

Indexed keywords

ADENOSINE TRIPHOSPHATE; ANTIDEPRESSANT AGENT; CITALOPRAM; DESIPRAMINE; DIZOCILPINE; HYPERICUM EXTRACT; IMIPRAMINE; MAGNESIUM; MAGNESIUM ASPARTATE; MAGNESIUM CHLORIDE; MAGNESIUM GLYCINATE; MAGNESIUM HYDROASPARTATE; MAGNESIUM ION; MAGNESIUM SALT; MAGNESIUM SULFATE; MAGNESIUM TAURINATE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; PSYCHOSTIMULANT AGENT; PYRIDOXINE; SILDENAFIL; THIAMINE; TIANEPTINE; UNCLASSIFIED DRUG; ZINC;

ANTIDEPRESSANT ACTIVITY; DEPRESSION; DIARRHEA; DIET SUPPLEMENTATION; DISEASE SEVERITY; DOSE RESPONSE; DRUG ANTAGONISM; DRUG BIOAVAILABILITY; DRUG EFFICACY; DRUG MECHANISM; DRUG MEGADOSE; DRUG POTENTIATION; DRUG SAFETY; DRUG SYNTHESIS; DRUG TOLERABILITY; HUMAN; LOW DRUG DOSE; MAGNESIUM BLOOD LEVEL; NONHUMAN; PUERPERAL DEPRESSION; REVIEW;

ANIMALS; ANTIDEPRESSIVE AGENTS; DEPRESSIVE DISORDER; HUMANS; MAGNESIUM; MAGNESIUM DEFICIENCY;

EID: 84884472397     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: 10.1016/S1734-1140(13)71032-6     Document Type: Review

References (96)

1. + pump in L-glutamate clearance by cultured rat cortical astrocytes. Biol Pharm Bull, 2000, 23, 1051-1054.
2. Alexander PE, van Kammen DP, Bunney WE, Jr.: Serum calcium and magnesium levels in schizophrenia. II. Possible relationship to extrapyramidal symptoms. Arch Gen Psychiatry, 1979, 36, 1372-1377. (Pubitemid 11145674)
3. 31P-NMR, spectroscopy and a unique magnesium ion-selective electrode. Alcohol Clin Exp Res, 1994, 18, 1057-1068. (Pubitemid 24345508)
4. Banki CM, Arato M, Kilts CD: Aminergic studies and cerebrospinal fluid cations in suicide. Ann NY Acad Sci, 1986, 487, 221-230.
5. Banki CM, Vojnik M, Papp Z, Balla KZ, Arato M: Cerebrospinal fluid magnesium and calcium related to amine metabolites, diagnosis, and suicide attempts. Biol Psychiatry, 1985, 20, 163-171. (Pubitemid 16051868)
6. Barragan-Rodriguez L, Rodriguez-Moran M, Guerrero-Romero F: Depressive symptoms and hypomagnesemia in older diabetic subjects. Arch Med Res, 2007, 38, 752-756. (Pubitemid 47368717)
7. Barragan-Rodriguez L, Rodriguez-Moran M, Guerrero-Romero F: Efficacy and safety of oral magnesium supplementation in the treatment of depression in the elderly with type 2 diabetes: a randomized, equivalent trial. Magnes Res, 2008, 21, 218-223.
8. Cade JF: A significant elevation of plasma magnesium levels in schizophrenia and depressive states. Med J Aust, 1964, 1, 195-196.
9. Carafoli E: Calcium-a universal carrier of biological signals. Delivered on 3 July 2003 at the Special FEBS Meeting in Brussels. FEBS J, 2005, 272, 1073-1089. (Pubitemid 40314928)
10. Cardoso CC, Lobato KR, Binfare RW, Ferreira PK, Rosa AO, Santos AR, Rodrigues AL: Evidence for the involvement of the monoaminergic system in the antidepressant-like effect of magnesium. Prog Neuropsychopharmacol Biol Psychiatry, 2009, 33, 235-242.
11. Chollet D, Franken P, Raffin Y, Malafosse A, Widmer J, Tafti M: Blood and brain magnesium in inbred mice and their correlation with sleep quality. Am J Physiol Regul Integr Comp Physiol, 2000, 279, R2173-R2178.
12. Connolly E, Worthley LI: Intravenous magnesium. Crit Care Resusc, 1999, 1, 162-172.
13. Cox IM, Campbell MJ, Dowson D: Red blood cell magnesium and chronic fatigue syndrome. Lancet, 1991, 337, 757-760.
14. Danysz W, Zajaczkowski W, Parsons CG: Modulation of learning processes by ionotropic glutamate receptor ligands. Behav Pharmacol, 1995, 6, 455-474.
15. DasGupta K: Treatment of depression in elderly patients: recent advances. Arch Fam Med, 1998, 7, 2742-2780.
16. Decollogne S, Tomas A, Lecerf C, Adamowicz E, Seman M: NMDA receptor complex blockade by oral administration of magnesium: comparison with MK-801. Pharmacol Biochem Behav, 1997, 58, 261-268. (Pubitemid 27334381)
17. Devi PR, Kumar L, Singhi SC, Prasad R, Singh M: Intravenous magnesium sulfate in acute severe asthma not responding to conventional therapy. Indian Pediatr, 1997, 34, 389-397. (Pubitemid 27264645)
18. Dube L, Granry JC: The therapeutic use of magnesium in anesthesiology, intensive care and emergency medicine: a review. Can J Anaesth, 2003, 50, 732-746. (Pubitemid 37321981)
19. Durlach J, Durlach V, Bac P, Bara M, Guiet-Bara A: Magnesiumand therapeutics. Magnes Res, 1994, 7, 313-328.
20. Eby GA, Eby KL: Rapid recovery from major depression using magnesium treatment. Med Hypotheses, 2006, 67, 362-370. (Pubitemid 43825609)
21. Eby GA, III, Eby KL: Magnesium for treatment-resistant depression: a review and hypothesis. Med Hypotheses, 2010, 74, 649-660.
22. Eby GA, Eby KL, Murck H: Magnesium and major depression. In: Magnesium in the Central Nervous System. Eds. Vink R, Nechifor M, University of Adelaide Press, Adelaide, 2011, 313-330.
23. Elovainio M, Keltikangas-Jarvinen L, Pulkki-Raback L, Kivimaki M, Puttonen S, Viikari L, Rasanen L et al.: Depressive symptoms and C-reactive protein: the Cardiovascular Risk in Young Finns Study. Psychol Med, 2006, 36, 797-805. (Pubitemid 43744773)
24. 4 in Gitelman's syndrome. Intern Med, 2004, 43, 410-414. (Pubitemid 38842508)
25. Facchinetti F, Borella P, Sances G, Fioroni L, Nappi RE, Genazzani AR: Oral magnesium successfully relieves premenstrual mood changes. Obstet Gynecol, 1991, 78, 177-181.
26. Firoz M, Graber M: Bioavailability of US commercial magnesium preparations. Magnes Res, 2001, 14, 257-262.
27. Frakes MA, Richardson LE: Magnesium sulfate therapy in certain emergency conditions. Am J Emerg Med, 1997, 15, 182-187. (Pubitemid 27147042)
28. Frazer A, Ramsey TA, Swann A, Bowden C, Brunswick D, Garver D, Secunda S: Plasma and erythrocyte electrolytes in affective disorders. J Affect Disord, 1983, 5, 103-113. (Pubitemid 13120404)
29. Frizel D, Coppen A, Marks V: Plasma magnesium and calcium in depression. Br J Psychiatry, 1969, 115, 1375-1377.
30. Fromm L, Heath DL, Vink R, Nimmo AJ: Magnesium attenuates post-traumatic depression/anxiety following diffuse traumatic brain injury in rats. J Am Coll Nutr, 2004, 23, 529S-533S.
31. Gundersen V, Danbolt NC, Ottersen OP, Storm-Mathisen J: Demonstration of glutamate/aspartate uptake activity in nerve endings by use of antibodies recognizing exogenous D-aspartate. Neuroscience, 1993, 57, 97-111. (Pubitemid 23325637)
32. Hasey GM, D'Alessandro E, Cooke RG, Warsh JJ: The interface between thyroid activity, magnesium, and depression: a pilot study. Biol Psychiatry, 1993, 33, 133-135. (Pubitemid 23069199)
33. Hashizume N, Mori M: An analysis of hypermagnesemia and hypomagnesemia. Jpn J Med, 1990, 29, 368-372.
34. 2+ supplementation reverses age-related neuroendocrine and sleep EEG changes in humans. Pharmacopsychiatry, 2002, 35, 135-143. (Pubitemid 34876179)
35. 2+ elicits persistent suppression of LTP at hippocampal CA1 synapses via PKC activation. J Neurophysiol, 2000, 84, 1279-1288.
36. 2O) solution and pyridoxine hydrochloride on erythrocyte magnesium depletion and behaviour of rats after threemonth alcoholization. Magnes Res, 2002, 15, 179-189.
37. Imada Y, Yoshioka S, Ueda T, Katayama S, Kuno Y, Kawahara R: Relationships between serum magnesium levels and clinical background factors in patients with mood disorders. Psychiatry Clin Neurosci, 2002, 56, 509-514.
38. Iosifescu DV, Bolo NR, Nierenberg AA, Jensen JE, Fava M, Renshaw PF: Brain bioenergetics and response to triiodothyronine augmentation in major depressive disorder. Biol Psychiatry, 2008, 63, 1127-1134.
39. 31P-MRS. Magnes Res, 2008, 21, 157-162.
40. Jabotinsky-Rubin K, Durst R, Levitin LA, Moscovich DG, Silver H, Lerner J, Van Praag H, Gardner EL: Effects of haloperidol on human plasma magnesium. J Psychiatr Res, 1993, 27, 155-159. (Pubitemid 23234198)
41. Jacka FN, Overland S, Stewart R, Tell GS, Bjelland I, Mykletun A: Association between magnesium intake and depression and anxiety in community-dwelling adults: the Hordaland Health Study. Aust N Z J Psychiatry, 2009, 43, 45-52.
42. Joffe RT, Levitt AJ, Young LT: The thyroid, magnesium and calcium in major depression. Biol Psychiatry, 1996, 40, 428-429. (Pubitemid 26301078)
43. Kantak KM: Magnesium deficiency alters aggressive behavior and catecholamine function. Behav Neurosci, 1988, 102, 304-311.
44. Labeeuw M, Pozet N, Zech P, Traeger J: Role of magnesium in the physiopathology and treatment of calcium renal lithiasis. Presse Med, 1987, 16, 25-27. (Pubitemid 17001834)
45. Lawley SI, Kantak KM: Magnesium-induced conditioned place preference in mice. Pharmacol Biochem Behav, 1990, 36, 539-545. (Pubitemid 20223020)
46. Levine J, Stein D, Rapoport A, Kurtzman L: High serum and cerebrospinal fluid Ca/Mg ratio in recently hospitalized acutely depressed patients. Neuropsychobiology, 1999, 39, 63-70. (Pubitemid 29118952)
47. Lindberg JS, Zobitz MM, Poindexter JR, Pak CY: Magnesium bioavailability from magnesium citrate and magnesium oxide. J Am Coll Nutr, 1990, 9, 48-55.
48. Linder J, Brismar K, Beck-Friis J, Saaf J, Wetterberg L: Calcium and magnesium concentrations in affective disorder: difference between plasma and serum in relation to symptoms. Acta Psychiatr Scand, 1989, 80, 527-537. (Pubitemid 20046935)
49. Liukkonen T, Silvennoinen-Kassinen S, Jokelainen J, Rasanen P, Leinonen M, Meyer-Rochow VB, Timonen M: The association between C-reactive protein levels and depression: Results from the northern Finland 1966 birth cohort study. Biol Psychiatry, 2006, 60, 825-830. (Pubitemid 44550038)
50. Malpuech-Brugere C, Nowacki W, Daveau M, Gueux E, Linard C, Rock E, Lebreton J et al.: Inflammatory response following acute magnesium deficiency in the rat. Biochim Biophys Acta, 2000, 1501, 91-98. (Pubitemid 30323647)
51. Mark LP, Prost RW, Ulmer JL, Smith MM, Daniels DL, Strottmann JM, Brown WD, Hacein-Bey L: Pictorial review of glutamate excitotoxicity: fundamental concepts for neuroimaging. AJNR Am J Neuroradiol, 2001, 22, 1813-1824. (Pubitemid 33091945)
52. Mazzotta G, Sarchielli P, Alberti A, Gallai V: Electromyographical ischemic test and intracellular and extracellular magnesium concentration in migraine and tension-type headache patients. Headache, 1996, 36, 357-361. (Pubitemid 26234957)
53. 2+ blockade site of an N-methyl-Daspartate (NMDA) receptor with unnatural amino acid mutagenesis. ACS Chem Biol, 2006, 1, 227-234.
54. Mildvan AS: Role of magnesium and other divalent cations in ATP-utilizing enzymes. Magnesium, 1987, 6, 28-33. (Pubitemid 17021368)
55. Mousain-Bosc M, Roche M, Rapin J, Bali JP: Magnesium VitB6 intake reduces central nervous system hyperexcitability in children. J Am Coll Nutr, 2004, 23, 545S-548S.
56. Murck H: Magnesium and affective disorders. Nutr Neurosci, 2002, 5, 375-389. (Pubitemid 35469537)
57. Muroyama A, Inaka M, Matsushima H, Sugino H, Marunaka Y, Mitsumoto Y: Enhanced susceptibility to MPTP neurotoxicity in magnesium-deficient C57BL/6N mice. Neurosci Res, 2009, 63, 72-75.
58. Naylor GJ, Fleming LW, Stewart WK, McNamee HB, Le PD: Plasma magnesium and calcium levels in depressive psychosis. Br J Psychiatry, 1972, 120, 683-684.
59. Nechifor M: Interactions between magnesium and psychotropic drugs. Magnes Res, 2008, 21, 97-100.
60. Nechifor M: Magnesium in major depression. Magnes Res, 2009, 22, 163S-166S.
61. Nikseresht S, Etebary S, Karimian M, Nabavizadeh F, Zarrindast MR, Sadeghipour HR: Acute administration of Zn, Mg, and thiamine improves postpartum depression conditions in mice. Arch Iran Med, 2012, 15, 306-311.
62. Nowak G, Poleszak E, Sowa-Kućma M, Pilc A: Magnesium and glutamate interaction in depression and antidepressant therapy. Biol Psychiatry, 2010, 67, 195S.
63. Nowak L, Bregestovski P, Ascher P, Herbet A, Prochiantz A: Magnesium gates glutamate-activated channels in mouse central neurones. Nature, 1984, 307, 462-465. (Pubitemid 14132062)
64. Ohba S, Hiramatsu M, Edamatsu R, Mori I, Mori A: Metal ions affect neuronal membrane fluidity of rat cerebral cortex. Neurochem Res, 1994, 19, 237-241. (Pubitemid 24054792)
65. Pampallona S, Bollini P, Tibaldi G, Kupelnick B, Munizza C: Patient adherence in the treatment of depression. Br J Psychiatry, 2002, 180, 104-109. (Pubitemid 34142778)
66. Papadopol V, Tuchendria E, Palamaru I: Magnesium and some psychological features in two groups of pupils (magnesium and psychic features). Magnes Res, 2001, 14, 27-32. (Pubitemid 33644576)
67. Penninx BW, Kritchevsky SB, Yaffe K, Newman AB, Simonsick EM, Rubin S, Ferrucci L et al.: Inflammatory markers and depressed mood in older persons: results from the health, aging and body composition study. Biol Psychiatry, 2003, 54, 566-572. (Pubitemid 37289443)
68. Poleszak E: Modulation of antidepressant-like activity of magnesium by serotonergic system. J Neural Transm, 2007, 114, 1129-1134. (Pubitemid 47313166)
69. Poleszak E, Szewczyk B, Ke{ogonek}dzierska E, Wlaź P, Pilc A, Nowak G: Antidepressant-and anxiolytic-like activity of magnesium in mice. Pharmacol Biochem Behav, 2004, 78, 7-12. (Pubitemid 38670508)
70. Poleszak E, Szewczyk B, Wlaź A, Fidecka S, Wlaź P, Pilc A, Nowak G: D-serine, a selective glycine/Nmethyl-D-aspartate receptor agonist, antagonizes the antidepressant-like effects of magnesium and zinc in mice. Pharmacol Rep, 2008, 60, 996-1000.
71. Poleszak E, Wlaź P, Ke{ogonek}dzierska E, Nieoczym D, Wróbel A, Fidecka S, Pilc A, Nowak G: NMDA/glutamate mechanism of antidepressant-like action of magnesium in forced swim test in mice. Pharmacol Biochem Behav, 2007, 88, 158-164. (Pubitemid 350115999)
72. Poleszak E, Wlaź P, Ke{ogonek}dzierska E, Nieoczym D, Wyska E, Szymura-Oleksiak J, Fidecka S et al.: Immobility stress induces depression-like behavior in the forced swim test in mice: effect of magnesium and imipramine. Pharmacol Rep, 2006, 58, 746-752. (Pubitemid 44741694)
73. Poleszak E, Wlaź P, Ke{ogonek}dzierska E, Radziwoń-Zaleska M, Pilc A, Fidecka S, Nowak G: Effects of acute and chronic treatment with magnesium in the forced swim test in rats. Pharmacol Rep, 2005, 57, 654-658.
74. Poleszak E, Wlaź P, Szewczyk B, Ke{ogonek}dzierska E, Wyska E, Librowski T, Szymura-Oleksiak J et al.: Enhancement of antidepressant-like activity by joint administration of imipramine and magnesium in the forced swim test: Behavioral and pharmacokinetic studies in mice. Pharmacol Biochem Behav, 2005, 81, 524-529. (Pubitemid 40966798)
75. Rasmussen HH, Mortensen PB, Jensen IW: Depression and magnesium deficiency. Int J Psychiatry Med, 1989, 19, 57-63. (Pubitemid 19137185)
76. H]glutamate transport activity: pharmacologic specificity and regulation by sodium and potassium. J Neurochem, 1993, 60, 167-179. (Pubitemid 23006715)
77. Sherwood RA, Rocks BF, Stewart A, Saxton RS: Magnesium and the premenstrual syndrome. Ann Clin Biochem, 1986, 23, 667-670. (Pubitemid 17189151)
78. Singewald N, Sinner C, Hetzenauer A, Sartori SB, Murck H: Magnesium-deficient diet alters depressionand anxiety-related behavior in mice-influence of desipramine and Hypericum perforatum extract. Neuropharmacology, 2004, 47, 1189-1197. (Pubitemid 39572710)
79. Socała K, Nieoczym D, Poleszak E, Wlaź P: Influence of the phosphodiesterase type 5 inhibitor, sildenafil, on antidepressant-like activity of magnesium in the forced swim test in mice. Pharmacol Rep, 2012, 64, 205-211.
80. Spasov AA, Iezhitsa IN, Kharitonova MV, Kravchenko MS: Depression-like and anxiety-related behaviour of rats fed with magnesium-deficient diet. Zh Vyssh Nerv Deiat Im I P Pavlova, 2008, 58, 476-485.
81. Szewczyk B, Poleszak E, Pilc A, Nowak G: Ionic glutamate modulators in depression (Zinc, Magnesium). In: Glutamate-based Therapies for Psychiatric Disorders. Ed. Skolnick P, Springer, Basel, 2010, 21-38.
82. Szewczyk B, Poleszak E, Sowa-Kućma M, Siwek M, Dudek D, Ryszewska-Pokraoeniewicz B, Radziwoń-Zaleska M et al.: Antidepressant activity of zinc and magnesium in view of the current hypotheses of antidepressant action. Pharmacol Rep, 2008, 60, 588-589.
83. Tomita R, Fujisaki S, Ikeda T, Fukuzawa M: Role of nitric oxide in the colon of patients with slow-transit constipation. Dis Colon Rectum, 2002, 45, 593-600. (Pubitemid 34507232)
84. Wacker WE, Parisi AF: Magnesium metabolism. N Engl J Med, 1968, 278, 712-717.
85. Walker AF, Marakis G, Christie S, Byng M: Mg citrate found more bioavailable than other Mg preparations in a randomised, double-blind study. Magnes Res, 2003, 16, 183-191. (Pubitemid 37386916)
86. Weglicki WB, Phillips TM, Freedman AM, Cassidy MM, Dickens BF: Magnesium-deficiency elevates circulating levels of inflammatory cytokines and endothelin. Mol Cell Biochem, 1992, 110, 169-173.
87. Weston PG: Magnesium as a sedative. Am J Psychiatry, 1921, 78, 637-638.
88. Whittle N, Li L, Chen WQ, Yang JW, Sartori SB, Lubec G, Singewald N: Changes in brain protein expression are linked to magnesium restriction-induced depression-like behavior. Amino Acids, 2011, 40, 1231-1248.
89. Widmer J, Bovier P, Karege F, Raffin Y, Hilleret H, Gaillard JM, Tissot R: Evolution of blood magnesium, sodium and potassium in depressed patients followed for three months. Neuropsychobiology, 1992, 26, 173-179. (Pubitemid 23095703)
90. Widmer J, Henrotte JG, Raffin Y, Bovier P, Hilleret H, Gaillard JM: Relationship between erythrocyte magnesium, plasma electrolytes and cortisol, and intensity of symptoms in major depressed patients. J Affect Disord, 1995, 34, 201-209.
91. Widmer J, Stella N, Raffin Y, Bovier P, Gaillard JM, Hilleret H, Tissot R: Blood magnesium, potassium, sodium, calcium and cortisol in drug-free depressed patients. Magnes Res, 1993, 6, 33-41.
92. 2+, phorbol esters, and ATP. J Biol Chem, 1985, 260, 15718-15722. (Pubitemid 16173201)
93. 2+ ratio in major depressive disorder. Neuropsychobiology, 1996, 34, 26-28. (Pubitemid 26300838)
94. Zehender M: Magnesium as an anti-arrhythmic therapy principle in supraventricular and ventricular cardiac arrhythmias. Z Kardiol, 1996, 85 Suppl 6, 135-145. (Pubitemid 26419585)
95. Zhang A, Altura BT, Altura BM: Ethanol-induced contraction of cerebral arteries in diverse mammals and its mechanism of action. Eur J Pharmacol, 1993, 248, 229-236. (Pubitemid 23296341)
96. Zieba A, Kata R, Dudek D, Schlegel-Zawadzka M, Nowak G: Serum trace elements in animal models and human depression: Part III. Magnesium. Relationship with copper. Hum Psychopharmacol, 2000, 15, 631-635. (Pubitemid 32121120)